-
DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update
08 Aug 2024 03:01 GMT
… 2024 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX), a late- … acute organ injury and cancer, today announced that the … acute organ injury and cancer. Larsucosterol, DURECT’s … is a trademark of DURECT Corporation. Other referenced trademarks belong …
-
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
21 May 2024 16:20 GMT
… acute organ injury and cancer, today announced that … acute organ injury and cancer. Larsucosterol, DURECT… is a trademark of DURECT Corporation. Other referenced trademarks belong … 47;news-releases/durect-corporation-receives-fda-breakthrough-therapy …
-
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
14 May 2024 12:04 GMT
… 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial … , including acute organ injury and cancer. Larsucosterol, DURECT's … health authorities for any indication.
DURECT CORPORATION
CONDENSED STATEMENTS OF OPERATIONS AND …
-
DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update
08 May 2024 13:46 GMT
… acute organ injury and cancer, today announced that the … acute organ injury and cancer. Larsucosterol, DURECT… is a trademark of DURECT Corporation. Other referenced trademarks belong … update-302138813.html
SOURCE DURECT Corporation
Company Codes: NASDAQ- …
-
DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis
30 Apr 2024 17:28 GMT
… acute organ injury and cancer, today announced acceptance … acute organ injury and cancer. Larsucosterol, DURECT… ;news-releases/durect-corporation-announces-late-breaking-oral … hepatitis-302131136.html
SOURCE DURECT Corporation
Company Codes: NASDAQ- …
-
DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript
01 Apr 2024 18:39 GMT
… Transcript March 27, 2024
DURECT Corporation beats earnings expectations. … afternoon and welcome to DURECT Corporation’s fourth quarter 2023 … A Session Follow Durect Corp (NASDAQ:DRRX) Follow Durect Corp (NASDAQ:DRRX) … as die from breast cancer. And it’s a …
-
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
28 Mar 2024 11:25 GMT
… 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial … , including acute organ injury and cancer. Larsucosterol, DURECT's … health authorities for any indication.
DURECT CORPORATION
CONDENSED STATEMENTS OF OPERATIONS AND …
-
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
21 Mar 2024 08:47 GMT
… acute organ injury and cancer, today announced that the … acute organ injury and cancer. Larsucosterol, DURECT… is a trademark of DURECT Corporation. Other referenced trademarks belong … update-302095096.html
SOURCE DURECT Corporation
Company Codes: NASDAQ- …
-
DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
08 Feb 2024 10:46 GMT
… , 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that … , including acute organ injury and cancer. Larsucosterol, DURECT's lead … -sciences-conference-302056826.html
SOURCE DURECT Corporation
Company Codes: NASDAQ-NMS:DRRX
-
DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update
09 Nov 2023 22:19 GMT
… #47;PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late … acute organ injury and cancer, today announced that the … acute organ injury and cancer. Larsucosterol, DURECT… is a trademark of DURECT Corporation. Other referenced trademarks belong …